Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: A multi-center study in China

被引:92
作者
Lu, Ming-De
Yu, Xiao-Ling
Li, An-Hua
Jiang, Tian-An
Chen, Min-Hua
Zhao, Bao-Zhen
Zhou, Xiao-Dong
Wang, Jin-Rui
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] PLA, Gen Hosp, Beijing, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[5] Peking Univ, Sch Oncol, Beijing, Peoples R China
[6] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China
[7] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China
[8] Peking Univ, Hosp 3, Beijing, Peoples R China
关键词
hepatocellular carcinoma; percutaneous thermal ablation; contrast-enhanced US;
D O I
10.1016/j.ultrasmedbio.2007.05.004
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
To evaluate the ability of contrast enhanced ultrasound (CEUS) in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma (HCC) in comparison with contrast enhanced computed tomography (CECT) and/or magnetic resonance imaging (CEMRI). A total of 151 patients were enrolled in the study. Before the radio-frequency (RF) or microwave ablation treatment, tumor vascularity was assessed in 139 patients with three imaging modalities i.e., US (139 exams), CEUS (139 exams) and CECT (103 exams)/CEMR (36 exams). CEUS examination was performed using a sulphur hexafluoride-filled microbubble contrast agent (SonoVue (R), Bracco, Milan, Italy) and real-time contrast-specific imaging techniques. Within 30 +/- 7 d after the ablation procedure, 118/139 patients were monitored to assess the tumor response to treatment. Before ablation, contrast enhancement within tumor was observed in 129/139 (92.8%) patients with CEUS and 133/139 (95.7%) patients with CECT/CEMRI. Compared with CECT/CEMRI, CEUS sensitivity and accuracy in detecting tumor vascularity were 97.0% and 94.2%, respectively. One month after treatment, no enhancement was seen in 110/118 (93.2%) both on CEUS and CECT/CEMRI. Concordance between CEUS and CECT/CEMR on the presence of residual vascularization was obtained in four patients (true positive). The specificity and accuracy of CEUS in detecting tumor vascularity were 98.2% and 96.6%, respectively. The periprocedural impact of SonoVue administration on the assessment of treatment extent was also evaluated in a subgroup of patients and CEUS showed its superiority compared with baseline US in defining treatment outcome. In conclusion, in the detection of HCC tumor vascularity and assessment of response to thermal ablation after 1 month, real time CEUS provided results comparable to those obtained with CECT/CEMRI. CEUS examination proved to be a safe and easy to access procedure, with potential for diagnostic impact in the clinical practice. (E-mail: lumd@21cn.com) (c) 2007 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:1736 / 1749
页数:14
相关论文
共 50 条
  • [41] Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT
    Inoue, Tatsuo
    Kudo, Masatoshi
    Hatanaka, Kinuyo
    Arizumi, Tadaaki
    Takita, Masahiro
    Kitai, Satoshi
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Ueshima, Kazuomi
    Nishida, Naoshi
    ONCOLOGY, 2013, 84 : 51 - 57
  • [42] Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
    Zhang, Hai-Chun
    Zhu, Ting
    Hu, Rong-Fei
    Wu, Long
    ULTRASONOGRAPHY, 2020, 39 (04) : 356 - 366
  • [43] The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy
    Chen, Min-Hua
    Wu, Wei
    Yang, Wei
    Dai, Ying
    Gao, Wen
    Yin, Shan-Shan
    Yan, Kun
    JOURNAL OF ULTRASOUND IN MEDICINE, 2007, 26 (08) : 1055 - 1063
  • [44] Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma
    Nishigaki, Yoichi
    Hayashi, Hideki
    Tomita, Eiichi
    Suzuki, Yusuke
    Watanabe, Naoki
    Watanabe, Satoshi
    Watanabe, Chiaki
    Takagi, Yui
    Kato, Tomohiro
    Naiki, Takafumi
    HEPATOLOGY RESEARCH, 2015, 45 (04) : 432 - 440
  • [45] Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound
    Ju, Jin-Xiu
    Zeng, Qing-Jing
    Xu, Er-Jiao
    He, Xu-Qi
    Tan, Lei
    Huang, Qian-Nan
    Li, Kai
    Zheng, Rong-Qin
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 (01) : 785 - 793
  • [46] Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST
    Ming Liu
    Man-xia Lin
    Ming-de Lu
    Zuo-feng Xu
    Ke-guo Zheng
    Wei Wang
    Ming Kuang
    Wen-quan Zhuang
    Xiao-yan Xie
    European Radiology, 2015, 25 : 2502 - 2511
  • [47] Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST
    Liu, Ming
    Lin, Man-xia
    Lu, Ming-de
    Xu, Zuo-feng
    Zheng, Ke-guo
    Wang, Wei
    Kuang, Ming
    Zhuang, Wen-quan
    Xie, Xiao-yan
    EUROPEAN RADIOLOGY, 2015, 25 (08) : 2502 - 2511
  • [48] Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma
    Zhang, Libo
    Gu, Junyi
    Li, Ya
    Ren, Zhen
    Zhang, Bo
    Yu, Zuoren
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [49] The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (≤3 cm) in patients with cirrhosis
    Chen, Min Hua
    Dai, Ying
    Yan, Kun
    Fan, Zhi Hui
    Yin, Shan Shan
    Yang, Wei
    Wu, Wei
    Wang, Yan Bin
    Li, Ji You
    HEPATOLOGY RESEARCH, 2006, 35 (04) : 281 - 288
  • [50] Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: The role of dynamic contrast enhanced ultrasound
    Zocco, Maria Assunta
    Garcovich, Matteo
    Lupascu, Andrea
    Di Stasio, Enrico
    Roccarina, Davide
    Annicchiarico, Brigida Elenora
    Riccardi, Laura
    Ainora, Maria Elena
    Ponziani, Francesca
    Caracciolo, Gianluigi
    Rapaccini, Gian Lodovico
    Landolfi, Raffaele
    Siciliano, Massimo
    Pompili, Maurizio
    Gasbarrini, Antonio
    JOURNAL OF HEPATOLOGY, 2013, 59 (05) : 1014 - 1021